Traxoprodil mesylate
≥98% (HPLC)
- Product Code: 71270
CAS:
188591-67-5
| Molecular Weight: | 423.52 g./mol | Molecular Formula: | C₂₁H₂₉NO₆S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD12546332 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
Traxoprodil mesylate is primarily investigated for its potential therapeutic applications in the field of neurology. It acts as a selective antagonist of the NMDA receptor, specifically targeting the NR2B subunit. This mechanism makes it a candidate for treating conditions associated with excessive glutamate activity, such as ischemic stroke, traumatic brain injury, and neurodegenerative diseases like Alzheimer's. By modulating glutamate signaling, it may help reduce excitotoxicity, which is a key factor in neuronal damage. Additionally, its neuroprotective properties are being explored for potential use in chronic pain management and psychiatric disorders, including depression and anxiety. Research is ongoing to fully understand its efficacy and safety in clinical settings.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £185.84 |
+
-
|
| 0.025 | 10-20 days | £749.48 |
+
-
|
Traxoprodil mesylate
Traxoprodil mesylate is primarily investigated for its potential therapeutic applications in the field of neurology. It acts as a selective antagonist of the NMDA receptor, specifically targeting the NR2B subunit. This mechanism makes it a candidate for treating conditions associated with excessive glutamate activity, such as ischemic stroke, traumatic brain injury, and neurodegenerative diseases like Alzheimer's. By modulating glutamate signaling, it may help reduce excitotoxicity, which is a key factor in neuronal damage. Additionally, its neuroprotective properties are being explored for potential use in chronic pain management and psychiatric disorders, including depression and anxiety. Research is ongoing to fully understand its efficacy and safety in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :